title: Payers' dilemma: looming costs for chronic conditions.
abstract: Biotech products for chronic conditions will be coming with regularity in the next few years, and these represent both a clinical opportunity and a financial challenge for health plans. So far, few payers have figured out how to make such treatments available without breaking the bank. The challenges ahead and strategies for handling them.
authors: Stephen
authors: S
authors: Herskovitz